ADAR1 CAPITAL MANAGEMENT, LLC
Adviser information for ADAR1 CAPITAL MANAGEMENT, LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Texas, United States |
Employees
| Total Number of Employees | 7 |
|---|---|
| Investment Advisory/Research | 6 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 3 | $507.8M |
| Non-Discretionary | 0 | $0 |
| Total | 3 | $507.8M |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 3 | $507.8M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 33 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
Principal Office
3503 WILD CHERRY DRIVEBUILDING 9
AUSTIN
TX
United States
Monday - Friday, 9AM-5PM
Tel: 512-254-3790, Fax: None
Chief Compliance Officer
STEPHEN SCIPIONE
HEAD OF OPERATIONS
3503 WILD CHERRY DRIVE
BUILDING 9
AUSTIN
TX
United States
Tel:
512-254-3790
S******@**********M
(Full email address available in API data)
Industry Affiliates
| ADAR1 CAPITAL MANAGEMENT GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| ADAR1 PARTNERS, LP | Hedge Fund | $484.1M | $1.0M | 113 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| SCHNEEBERGER, DANIEL, PAWEL | Individual | ADAR1 CAPITAL MANAGEMENT GP, LLC | MANAGING MEMBER | 11/2018 | > 75% |
| SCHNEEBERGER, DANIEL, PAWEL | Individual | – | MANAGING PARTNER | 11/2018 | > 75% |
| ADAR1 CAPITAL MANAGEMENT GP, LLC | Domestic Entity | – | GENERAL PARTNER | 11/2018 | < 5% |
| SCIPIONE, STEPHEN, THOMAS | Individual | – | HEAD OF OPERATIONS, CHIEF COMPLIANCE OFFICER | 01/2021 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| 2SEVENTY BIO INC | COMMON STOCK | 4K | 1K | – |
| 4D MOLECULAR THERAPEUTICS IN | COM | 42K | 2K | – |
| 89BIO INC | COM | 45K | 6K | – |
| 99 ACQUISITION GROUP INC | UNIT 99/99/9999 | 81K | 8K | – |
| AB ACTIVE ETFS INC | ULTRA SHORT INCM | 505K | 10K | – |
| ABBOTT LABS | COM | 343K | 3K | – |
| ABEONA THERAPEUTICS INC | COM NEW | 480K | 113K | – |
| ABIVAX SA | SPONSORED ADS | 357K | 27K | – |
| ABSCI CORPORATION | COM | 5M | 2M | – |
| ACADIA PHARMACEUTICALS INC | COM | 21K | 1K | – |
| ACASTI PHARMA INC | CL A | 3M | 960K | – |
| ACELYRIN INC | COM | 223K | 51K | – |
| ACHIEVE LIFE SCIENCES INC | COM | 3M | 542K | – |
| ACTINIUM PHARMACEUTICALS INC | COM | 556K | 75K | – |
| ADDEX THERAPEUTICS LTD | SPONSORED ADS | 7K | 900 | – |
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | 78K | 11K | – |
| AEROVATE THERAPEUTICS INC | COM | 410K | 247K | – |
| AEROVATE THERAPEUTICS INC | COM | 4K | 3K | – |
| AI TRANSN ACQUISITION CORP | UNIT 99/99/9999 | 79K | 8K | – |
| AIMFINITY INVESTMENT CORP I | *W EXP 99/99/999 | 362 | 18K | – |
| AKERO THERAPEUTICS INC | COM | 598K | 26K | – |
| ALECTOR INC | COM | 887K | 195K | – |
| ALGONQUIN PWR UTILS CORP | COM | 88K | 15K | – |
| ALKERMES PLC | SHS | 5M | 197K | – |
| ALNYLAM PHARMACEUTICALS INC | COM | 450K | 2K | – |
| AMPHASTAR PHARMACEUTICALS IN | COM | 28K | 700 | – |
| AMPLIFY ENERGY CORP NEW | COM | 20K | 3K | – |
| AMYLYX PHARMACEUTICALS INC | COM | 204K | 107K | – |
| AMYLYX PHARMACEUTICALS INC | COM | 19K | 10K | – |
| ANAPTYSBIO INC | COM | 4M | 156K | – |
| ANAPTYSBIO INC | COM | 38K | 2K | – |
| ANGIODYNAMICS INC | COM | 870K | 144K | – |
| APELLIS PHARMACEUTICALS INC | COM | 792K | 21K | – |
| APELLIS PHARMACEUTICALS INC | COM | 4K | 100 | – |
| APOGEE THERAPEUTICS INC | COM | 2M | 41K | – |
| APPLIED THERAPEUTICS INC | COM | 1M | 321K | – |
| ARBUTUS BIOPHARMA CORP | COM | 10M | 3M | – |
| ARCA BIOPHARMA INC | COM | 324K | 85K | – |
| ARCELLX INC | COMMON STOCK | 6K | 100 | – |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 14K | 2K | – |
| ARDELYX INC | COM | 519K | 70K | – |
| ARROWHEAD PHARMACEUTICALS IN | COM | 153K | 6K | – |
| ARVINAS INC | COM | 862K | 32K | – |
| ARYA SCIENCES ACQU CORP IV | CL A | 614K | 54K | – |
| ASCENDIS PHARMA A/S | SPONSORED ADR | 7M | 51K | – |
| ASTRAZENECA PLC | SPONSORED ADR | 8K | 100 | – |
| ASTRIA THERAPEUTICS INC | COM | 1M | 138K | – |
| AURA BIOSCIENCES INC | COM | 2M | 203K | – |
| AVANGRID INC | COM | 817K | 23K | – |
| AXSOME THERAPEUTICS INC | COM | 24K | 300 | – |
| BAUSCH PLUS LOMB CORP | COMMON SHARES | 93K | 6K | – |
| BEAM THERAPEUTICS INC | COM | 2M | 73K | – |
| BEIGENE LTD | SPONSORED ADR | 2M | 11K | – |
| BEYOND AIR INC | COM | 658K | 1M | – |
| BIOCRYST PHARMACEUTICALS INC | COM | 182K | 29K | – |
| BLACK HAWK ACQUISITION CORP | UNIT 99/99/9999 | 155K | 15K | – |
| BLUEBIRD BIO INC | COM | 6K | 6K | – |
| BOLT BIOTHERAPEUTICS INC | COM | 139K | 186K | – |
| BRIDGEBIO PHARMA INC | COM | 32M | 1M | – |
| BRIDGEBIO PHARMA INC | COM | 94K | 4K | – |
| BRIDGEBIO PHARMA INC | COM | 30K | 1K | – |
| CAPRICOR THERAPEUTICS INC | COM NEW | 97K | 20K | – |
| CARA THERAPEUTICS INC | COM | 41K | 159K | – |
| CASI PHARMACEUTICALS INC | ORD SHS | 45K | 8K | – |
| CELCUITY INC | COM | 23K | 1K | – |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 11K | 303 | – |
| CELLECTAR BIOSCIENCES INC | COM NEW | 2M | 682K | – |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 2M | 253K | – |
| CEREVEL THERAPEUTICS HLDNG I | COM | 4M | 93K | – |
| CEREVEL THERAPEUTICS HLDNG I | COM | 2M | 50K | – |
| CETUS CAP ACQUISITION CORP | RIGHT 03/31/2024 | 1K | 5K | – |
| CETUS CAP ACQUISITION CORP | *W EXP 01/31/202 | 130 | 5K | – |
| CG ONCOLOGY INC | COM | 406K | 13K | – |
| CHIMERIX INC | COM | 156K | 178K | – |
| COGENT COMMUNICATIONS HLDGS | COM NEW | 226K | 4K | – |
| CONTEXT THERAPEUTICS INC | COM | 1M | 645K | – |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 543K | 12K | – |
| CORTEVA INC | COM | 615K | 11K | – |
| CRINETICS PHARMACEUTICALS IN | COM | 3M | 75K | – |
| CULLINAN THERAPEUTICS INC | COM | 929K | 53K | – |
| CYTOKINETICS INC | COM NEW | 46M | 854K | – |
| CYTOKINETICS INC | COM NEW | 5K | 100 | – |
| CYTOMX THERAPEUTICS INC | COM | 698K | 572K | – |
| DAY ONE BIOPHARMACEUTICALS I | COM | 484K | 35K | – |
| DELCATH SYS INC | COM NEW | 2M | 198K | – |
| DENALI THERAPEUTICS INC | COM | 882K | 38K | – |
| EA SERIES TRUST | ALPHA ARCH 1-3 | 38M | 351K | – |
| EAGLE PHARMACEUTICALS INC | COM | 123K | 22K | – |
| ECD AUTOMOTIVE DESIGN INC | *W EXP 12/12/202 | 652 | 33K | – |
| EDGEWISE THERAPEUTICS INC | COM | 8M | 437K | – |
| ELEVATION ONCOLOGY INC | COM | 229K | 85K | – |
| ELIEM THERAPEUTICS INC | COM | 695K | 98K | – |
| EMBRACE CHANGE ACQUISITN COR | RIGHT 10/25/2026 | 2K | 18K | – |
| EMBRACE CHANGE ACQUISITN COR | *W EXP 10/25/202 | 378 | 18K | – |
| ENDEAVOR GROUP HLDGS INC | CL A COM | 287K | 11K | – |
| ENGENE HOLDINGS INC | COM | 6K | 600 | – |
| ENVVENO MEDICAL CORPORATION | COM | 1M | 202K | – |
| EQUILLIUM INC | COM | 98K | 141K | – |
| EQUILLIUM INC | COM | 6K | 9K | – |
| ERASCA INC | COM | 7K | 3K | – |
| ETON PHARMACEUTICALS INC | COM | 4K | 1K | – |
| EVOTEC AG | SPONSORED ADS | 45K | 9K | – |
| EXACT SCIENCES CORP | COM | 25K | 600 | – |
| FORTE BIOSCIENCES INC | COM | 86K | 159K | – |
| FOUR LEAF ACQUISITION CORP | *W EXP 03/15/202 | 360 | 8K | – |
| FULCRUM THERAPEUTICS INC | COM | 2M | 368K | – |
| FULCRUM THERAPEUTICS INC | COM | 124K | 20K | – |
| FUTURETECH II ACQUISITION CO | *W EXP 08/18/202 | 483 | 30K | – |
| GERON CORP | COM | 382K | 90K | – |
| GH RESEARCH PLC | ORDINARY SHARES | 22K | 2K | – |
| GLOBAL STAR ACQUISITION INC | RIGHT 06/21/2024 | 15K | 118K | – |
| GLOBAL STAR ACQUISITION INC | *W EXP 07/15/202 | 3K | 120K | – |
| GLYCOMIMETICS INC | COM | 38K | 135K | – |
| GLYCOMIMETICS INC | COM | 38K | 135K | – |
| GOSSAMER BIO INC | COM | 480K | 533K | – |
| GOSSAMER BIO INC | COM | 18K | 20K | – |
| GRAIL INC | COM | 329K | 21K | – |
| GREENLIGHT CAPITAL RE LTD | CLASS A | 162K | 12K | – |
| GUARDANT HEALTH INC | COM | 982K | 34K | – |
| HELIX ACQUISITION CORP II | CL A ORD SHS | 4M | 404K | – |
| HIMS & HERS HEALTH INC | COM CL A | 19K | 940 | – |
| HOWARD HUGHES HOLDINGS INC | COM | 65K | 1K | – |
| IBIO INC | CON NEW | 1M | 570K | – |
| ICHOR HOLDINGS | SHS | 4K | 108 | – |
| IDEAYA BIOSCIENCES INC | COM | 11K | 300 | – |
| IKENA ONCOLOGY INC | COM | 77K | 47K | – |
| IMMUNOVANT INC | COM | 13M | 477K | – |
| INDIVIOR PLC | ORD | 1M | 70K | – |
| INSMED INC | COM PAR $.01 | 3M | 42K | – |
| INSMED INC | COM PAR $.01 | 10M | 150K | – |
| INSMED INC | COM PAR $.01 | 13M | 201K | – |
| INTELLIGENT BIO SOLUTIONS IN | COM | 208K | 108K | – |
| INVESCO QQQ TR | UNIT SER 1 | 1M | 3K | – |
| IONIS PHARMACEUTICALS INC | COM | 71K | 2K | – |
| IOVANCE BIOTHERAPEUTICS INC | COM | 180K | 22K | – |
| IRON HORSE ACQUISITIONS CORP | UNIT 10/15/2028 | 257K | 25K | – |
| ISHARES TR | 20 YR TR BD ETF | 184K | 2K | – |
| ISHARES TR | SHORT TREAS BD | 3M | 25K | – |
| ISHARES TR | RUSSELL 2000 ETF | 609K | 3K | – |
| ITEOS THERAPEUTICS INC | COM | 890K | 60K | – |
| J P MORGAN EXCHANGE TRADED F | ULTRA SHRT INC | 3M | 54K | – |
| JANUX THERAPEUTICS INC | COM | 331K | 8K | – |
| JVSPAC ACQUISITION CORP | UNIT 03/11/2024 | 313K | 30K | – |
| KALA BIO INC | COM NEW | 2M | 306K | – |
| KALVISTA PHARMACEUTICALS INC | COM | 142K | 12K | – |
| KEEN VISION ACQUISITION CORP | UNIT 99/99/9999 | 793K | 75K | – |
| KENSINGTON CAPITAL ACQUISITI | SHS CL A | 94K | 9K | – |
| KEROS THERAPEUTICS INC | COM | 25M | 549K | – |
| KEZAR LIFE SCIENCES INC | COM | 652K | 1M | – |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 2M | 114K | – |
| KIORA PHARMACEUTICALS INC | COM | 725K | 173K | – |
| KOHLS CORP | COM | 46K | 2K | – |
| KORRO BIO INC | COM | 244K | 7K | – |
| KYMERA THERAPEUTICS INC | COM | 2M | 51K | – |
| LEXARIA BIOSCIENCE CORP | COM NEW | 3K | 945 | – |
| LEXEO THERAPEUTICS INC | COM | 21K | 1K | – |
| LIGAND PHARMACEUTICALS INC | COM NEW | 75K | 890 | – |
| MASIMO CORP | COM | 5K | 38 | – |
| MERCK & CO INC | COM | 9M | 76K | – |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | 199K | 55K | – |
| MERUS N V | COM | 2M | 27K | – |
| MILESTONE PHARMACEUTICALS IN | COM | 267K | 202K | – |
| MINERALYS THERAPEUTICS INC | COM | 297K | 25K | – |
| MITEK SYS INC | COM NEW | 63K | 6K | – |
| MKS INSTRS INC | COM | 261K | 2K | – |
| MODERNA INC | COM | 594K | 5K | – |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 211K | 5K | – |
| MOVANO INC | COM | 387K | 1M | – |
| NCR ATLEOS CORPORATION | COM SHS | 27K | 1K | – |
| NCR VOYIX CORPORATION | COM | 25K | 2K | – |
| NEUROGENE INC | COM | 46K | 1K | – |
| NEXTCURE INC | COM | 142K | 89K | – |
| NOVO-NORDISK A S | ADR | 29K | 200 | – |
| NURIX THERAPEUTICS INC | COM | 73K | 4K | – |
| NUVEI CORPORATION | SUB VTG SHS | 162K | 5K | – |
| OAK WOODS ACQUISITION CORP | CL A | 326K | 30K | – |
| OAK WOODS ACQUISITION CORP | RIGHT 03/23/2028 | 8K | 30K | – |
| OAK WOODS ACQUISITION CORP | *W EXP 99/99/999 | 750 | 30K | – |
| OCULAR THERAPEUTIX INC | COM | 225K | 33K | – |
| OKLO INC | COM CL A | 8K | 1K | – |
| OLEMA PHARMACEUTICALS INC | COM | 217K | 20K | – |
| OMNIAB INC | COM | 3M | 713K | – |
| OPTINOSE INC | COM | 3K | 3K | – |
| OPTION CARE HEALTH INC | COM NEW | 332K | 12K | – |
| ORGANON & CO | COMMON STOCK | 52K | 3K | – |
| OVID THERAPEUTICS INC | COM | 15K | 19K | – |
| PASITHEA THERAPEUTICS CORP | COM NEW | 140K | 28K | – |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | 8M | 750K | – |
| PERRIGO CO PLC | SHS | 28K | 1K | – |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 698K | 70K | – |
| PFIZER INC | COM | 1M | 40K | – |
| PGIM ETF TR | PGIM ULTRA SH BD | 497K | 10K | – |
| PHARVARIS N V | COM | 38K | 2K | – |
| PIMCO ETF TR | 25YR+ ZERO U S | 225K | 3K | – |
| PLIANT THERAPEUTICS INC | COM | 108K | 10K | – |
| PMV PHARMACEUTICALS INC | COM | 81K | 50K | – |
| POLYPID LTD | COM | 447K | 104K | – |
| PONO CAP TWO INC | *W EXP 99/99/999 | 1K | 20K | – |
| PROTAGONIST THERAPEUTICS INC | COM | 56M | 2M | – |
| PROTHENA CORP PLC | SHS | 124K | 6K | – |
| PURETECH HEALTH PLC | ADS | 18K | 700 | – |
| PYXIS ONCOLOGY INC | COMMON STOCK | 33K | 10K | – |
| Q32 BIO INC | COM | 3M | 157K | – |
| QUINCE THERAPEUTICS INC | COM | 70K | 93K | – |
| RALLYBIO CORP | COM | 15K | 11K | – |
| RAPT THERAPEUTICS INC | COM | 23K | 8K | – |
| REGENXBIO INC | COM | 32K | 3K | – |
| RELMADA THERAPEUTICS INC | COM | 152K | 51K | – |
| RENOVORX INC | COM NEW | 401K | 355K | – |
| REZOLUTE INC | COM NEW | 9M | 2M | – |
| RHYTHM PHARMACEUTICALS INC | COM | 534K | 13K | – |
| ROCKET PHARMACEUTICALS INC | COM | 2K | 100 | – |
| ROIVANT SCIENCES LTD | SHS | 44M | 4M | – |
| ROYALTY PHARMA PLC | SHS CLASS A | 31M | 1M | – |
| SANOFI | SPONSORED ADR | 442K | 9K | – |
| SAREPTA THERAPEUTICS INC | COM | 703K | 4K | – |
| SAVARA INC | COM | 3M | 664K | – |
| SAVARA INC | COM | 20K | 5K | – |
| SAVARA INC | COM | 44K | 11K | – |
| SCHOLAR ROCK HLDG CORP | COM | 100K | 12K | – |
| SILENCE THERAPEUTICS PLC | ADS | 766K | 40K | – |
| SOLENO THERAPEUTICS INC | COM | 2M | 40K | – |
| SOLID BIOSCIENCES INC | COM NEW | 8M | 1M | – |
| SPDR S&P 500 ETF TR | TR UNIT | 4M | 8K | – |
| SPDR SER TR | BLOOMBERG 1-3 MO | 3M | 33K | – |
| SPERO THERAPEUTICS INC | COM | 1M | 919K | – |
| SPRUCE BIOSCIENCES INC | COM | 184K | 355K | – |
| SPYRE THERAPEUTICS INC | COM NEW | 827K | 35K | – |
| SSGA ACTIVE ETF TR | ULT SHT TRM BD | 2M | 48K | – |
| STEVANATO GROUP S P A | ORD SHS | 495K | 27K | – |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 60K | 2K | – |
| TARGET HOSPITALITY CORP | COM | 990K | 114K | – |
| TAYSHA GENE THERAPIES INC | COM SHS | 562K | 251K | – |
| TECTONIC THERAPEUTIC INC | COM | 6M | 357K | – |
| TERNS PHARMACEUTICALS INC | COM | 102K | 15K | – |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 2M | 103K | – |
| TG THERAPEUTICS INC | COM | 99K | 6K | – |
| THERAPEUTICSMD INC | COM NEW | 435K | 270K | – |
| THUNDER PWR HLDGS INC | COM | 2K | 2K | – |
| TMT ACQUISITION CORP | SHS | 549K | 50K | – |
| TMT ACQUISITION CORP | RIGHT 03/27/2028 | 17K | 50K | – |
| TOURMALINE BIO INC | COM | 271K | 21K | – |
| TRIPADVISOR INC | COM | 392K | 22K | – |
| TYRA BIOSCIENCES INC | COM | 5K | 300 | – |
| ULTRA CLEAN HLDGS INC | COM | 49K | 1K | – |
| UNIQURE NV | SHS | 5M | 1M | – |
| VANGUARD BD INDEX FDS | VANGUARD ULTRA | 3M | 55K | – |
| VAXART INC | COM NEW | 631K | 946K | – |
| VAXCYTE INC | COM | 925K | 12K | – |
| VENTYX BIOSCIENCES INC | COM | 30K | 13K | – |
| VERA THERAPEUTICS INC | CL A | 39K | 1K | – |
| VERVE THERAPEUTICS INC | COM | 215K | 44K | – |
| VIKING THERAPEUTICS INC | COM | 5M | 91K | – |
| VIR BIOTECHNOLOGY INC | COM | 979K | 110K | – |
| VIRIDIAN THERAPEUTICS INC | COM | 104K | 8K | – |
| VOYAGER THERAPEUTICS INC | COM | 147K | 19K | – |
| VYNE THERAPEUTICS INC | COM | 337K | 171K | – |
| WAVE LIFE SCIENCES LTD | SHS | 382K | 77K | – |
| WEST PHARMACEUTICAL SVSC INC | COM | 293K | 890 | – |
| WISDOMTREE TR | FLOATNG RAT TREA | 3M | 53K | – |
| XENON PHARMACEUTICALS INC | COM | 183K | 5K | – |
| XERIS BIOPHARMA HOLDINGS INC | COM | 2K | 1K | – |
| XILIO THERAPEUTICS INC | COM | 1K | 2K | – |
| ZAI LAB LTD | ADR | 381K | 22K | – |
| ZEVRA THERAPEUTICS INC | COM NEW | 10K | 2K | – |
| ZYVERSA THERAPEUTICS INC | COM | 36K | 10K | – |